| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C20H20N2O2 |
| Molar mass | 320.392 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Befuraline (DIV-154) is apsychoactive drug and member of thepiperazinechemical class which wasdeveloped inGermany in the 1970s.[1] Befuraline hasstimulant andantidepressant effects and has seen some use in Germany andFrance, although it has never become widely used.[2] Befuraline's activemetabolitebenzylpiperazine is likely to contribute to its effects.

A one-step coupling between coumarilic acid (benzofuran-2-carboxylic acid) [496-41-3] (1) andbenzylpiperazine (BzP) (2) gives an amide, and henceBefuraline (3).
Thispsychoactive drug-related article is astub. You can help Wikipedia byexpanding it. |